We report on a case of anti-N-Methyl-D-Aspartate receptor antibody encephalitis, and review cases and series previously published in the literature. Anti-N-Methyl-D-Aspartate receptor antibody encephalitis usually occurs in young female patients with no past medical history, in whom an ovarian teratoma is often detected. They subacutely develop predominantly psychiatric symptoms, followed by severe neurological disorders requiring transfer to the intensive care unit and prolonged ventilatory support. Complete or substantial recovery depends on early diagnosis, removal of the teratoma and immunotherapy. Our purpose is to focus intensivists' attention on this potentially lethal disorder, which should always be considered in young women admitted to the intensive care unit with characteristic neuropsychiatric disorders.
Disturbances of memory and behaviour, psychiatric symptoms and seizures can result from immunemediated encephalitis. These disorders can be paraneoplastic and may be associated with several antibodies.
Recently, a treatment-responsive paraneoplastic encephalitis associated with anti-N-Methyl-D-Aspartate receptor (NMDAR) antibodies has been identified 1 . Most patients are young females who develop predominantly psychiatric symptoms and in whom an ovarian teratoma is diagnosed. We report on a 41-year-old woman, admitted to our intensive care unit (ICU) with treatment-responsive NMDAR encephalitis.
CASE HISTORY
A 41-year-old woman with no past medical history was admitted to the psychiatry department in May 2009. After a viral-like syndrome, she developed short-time memory loss, strange olfactory feelings and then an acute behavioural disorder with agitation, deep anxiety, delusion and hallucinations.
After one week, her neurological condition rapidly worsened and she became confused and disoriented, with fever and dehydration. In June she was transferred to our ICU in order to rule out meningoencephalitis. On admission she had decreased consciousness (Glasgow Coma Scale=10). She was alternately drowsy and agitated, crying and mute, and had hallucinations. She developed catatonic attitudes, abnormal spontaneous movements with repetitive cycling movements of the lower limbs, facial grimacing and orgasmic-like behaviour episodes. Neurological examination was normal, with no neck stiffness. Temperature was 39°C, she was dehydrated and chest X-ray showed an aspiration pneumonia. Biological tests confirmed dehydration, inflammatory syndrome and confirmed alveolar hypoventilation. Cerebrospinal fluid (CSF) showed mononuclear-dominant white cells (52/mm 3 ), normal glucose and protein, no organisms on gram stain and sterile cultures. Electroencephalogram showed diffuse slowing without epileptiform patterns. Cranial computed tomography scan was normal, and brain magnetic resonance imaging showed T2 and FLAIR light hyperintensities in the right temporal lobe. Extensive bacteriological, virological and immunological studies performed on serum and CSF were negative. She received amoxycillin-clavulanic acid for aspiration pneumonia, and aciclovir (30 mg/kg/day) until negative polymerase chain reaction ruled out herpes simplex virus meningoencephalitis. After three weeks, as
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Anaesthesia and Intensive Care, Vol. 38, No. 4, July 2010 her neurological status showed no improvement, paraneoplastic encephalitis was suspected. Tumour blood markers were negative, but a whole body computed tomography scan revealed a left ovarian mass (54×40×66 mm), consistent with a cystic teratoma. NMDAR antibodies were identified in both serum and CSF, confirming NMDAR encephalitis. After five days of methylprednisolone (500 mg/day), her neurological condition dramatically improved. In July she underwent surgical salpingo-oophorectomy. Histopathology showed ovarian mature teratoma. Eight weeks after hospital admission her higher functions were normal. She was discharged from hospital and sent home.
DISCUSSION
In patients presenting with encephalitis, after excluding infectious aetiologies, paraneoplastic limbic encephalitis should be considered. Among paraneoplastic limbic encephalitis, NMDAR encephalitis, a newly identified limbic encephalitis 1 , seems to have a distinctive prognosis. Indeed, in a series including 100 adult and child patients, with a mix of retrospective and prospective diagnoses of NMDAR encephalitis 2 , neurological improvement was observed in more than 70% of patients, compared with less than 40% of patients with paraneoplastic limbic encephalitis related to other antineuronal antibodies 3 . To date, descriptions and publications of NMDAR encephalitis cases are limited to neurology literature. This is partly due to the fact that the diagnosis of this disorder is rarely established in ICU. Indeed, although the great majority of patients with NMDAR encephalitis undergo prolonged stays in ICU, this diagnosis is either not made in ICU or only after months of ventilatory support 2 . After reviewing the literature published after Dalmau's series 2 , concerning adult patients with a diagnosis of NMDAR encephalitis established prosectively (i.e. during hospital stay and not retrospectively from frozen sera or CSF), and displaying complete clinical descriptions 4-11 (cf . Table  1 ), we would like to underline several crucial points.
As previously described, NMDAR encephalitis occurs preferentially in young women. Most of them have neither a medical nor psychiatric past Complete recovery occurs in 90% of prospectively diagnosed cases of NMDAR encephalitis. In Dalmau's series, near complete recovery was observed in 92% of patients with early treatment of tumour, compared with near complete recovery in only 66% of patients with late or no treatment of tumour, or no tumour detected 2 . Thus, diagnosis and early removal of the tumour appear crucial. Adjunctive immunotherapy is usually started before surgery. This immunotherapy has not yet been codified, and mostly consists of high-dose corticosteroids, intravenous immunoglobulins and plasma exchanges 1,2,4-11 .
